Overview

Optimal Treatment of MRSA Throat Carriers

Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is to investigate the optimal way to treat MRSA throat carriers.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hvidovre University Hospital
Treatments:
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Criteria
Inclusion Criteria:

- Age ≥ 18 years

- MRSA carriage in the throat after first topical decolonization treatment (regardless
of previous swab results)

- Has completed one standard topical decolonization treatment

Exclusion Criteria:

- Pregnant or lactating woman

- Sexually active women in the reproductive age that do not use approved contraceptives
(appendix 4)

- Cannot read or speak Danish (the written participant information is in Danish)

- Skin infection or other active infections

- Activity in skin diseases such as eczema or psoriasis.

- MRSA isolate resistant to clindamycin (defined by inhibition zone size < 22 mm using
disk diffusion methodology) or resistant to mupirocin

- Allergy to clindamycin, chlorhexidine or mupirocin

- Taking medications that interact with clindamycin according to the medicine
information leaflet.

- MRSA active antibiotic treatment within 7 days before inclusion in the study or during
study period

- Followed by specialist due to liver disease

- Severe overweight (BMI > 35) or weight < 50 kg

- Indwelling percutaneous permanent devices such as intravenous catheters or urinary
tract catheters

- Daily contact with pigs or minks (decolonization therapy is generally not offered,
according to The National Board of Health)

- Nursing home resident or health care worker (they have a more frequent control swab
regime)

- Not being capable of completing another treatment successfully

- MRSA positive household members younger than 2 years (MRSA positive children below 2
years of age and their household members are generally not offered decolonization
treatment according to The National Board of Health)

- MRSA positive household members, where it is judged that further decolonization
attempts are not indicated